GREGORY FREITAG - Corporate Board Profile

Axogen, Inc.

Filing Date	Source Excerpt
2018-03-29	Gregory Freitag, JD, CPA, General Counsel, SVP Business Development and Director (Age 56) Mr. Freitag, JD, CPA, has been AxoGen’s General Counsel and a member of our Board of Directors since September 2011, has been AxoGen’s Senior Vice President Business Development since May 2014, and was AxoGen’s Chief Financial Officer (“CFO”) from September 2011 to May 2014 and August 2015 to March 2016. From June 2010 through September 2011, Mr. Freitag was the CEO, CFO and a board member of LecTec Corporation, an intellectual property licensing and holding company that merged with AxoGen in September 2011. From May 2009 to the present, Mr. Freitag has been a principal of FreiMc, LLC, a healthcare and life science consulting and advisory firm he founded that provides strategic guidance and business development advisory services. Prior to founding FreiMc, LLC, Mr. Freitag was a Director of Business Development at Pfizer Health Solutions, a former subsidiary of Pfizer, Inc., from January 2006 to May 2009. From July 2005 to January 2006, Mr. Freitag worked for Guidant Corporation in their business development group. Prior to Guidant Corporation, Mr. Freitag was the CEO of HTS Biosystems, a biotechnology tools start-up company, from March 2000 until its sale in early 2005. Mr. Freitag was the COO, CFO and General Counsel of Quantech, Ltd., a public point of care diagnostic company, from December 1995 to March 2000. Prior to that time, Mr. Freitag practiced corporate law in Minneapolis, Minnesota. Mr. Freitag is also a director of the Foundation Board of HealthEast Care System, a health care system in Minnesota, and PDS Biotechnology Corporation, a private, clinical stage Biopharmaceutical Company developing immunotherapies for cancer and other disease areas such as infectious disease. Mr. Freitag holds a JD from the University of Chicago and a BA Economics & Business and Law & Society from Macalester College, Minnesota. Mr. Freitag’s qualifications to serve on our Board of Directors include his proven leadership and experience as a senior level executive, his particular knowledge of public companies, including reporting, compliance and financial markets related thereto, his finance management and legal expertise and over 20 years of experience in the life sciences sector.
2019-06-27	Gregory Freitag, J.D., CPA, General Counsel and Director (Age 57) Mr. Freitag has been Axogen’s General Counsel and a member of our Board of Directors since September 2011.
2020-04-17	Gregory Freitag, J.D., CPA, General Counsel and Director (Age 58) Mr. Freitag has been Axogen’s General Counsel and a member of our Board of Directors since September 2011.
2021-03-31	Gregory Freitag, J.D., CPA, Director (Age 59) Mr. Freitag has been a member of our Board of Directors since September 2011. ... Mr. Freitag was an executive officer (but not a named executive officer) who did not receive additional compensation for his service as a director, and therefore is not included in the table below.
2022-04-14	Gregory Freitag, J.D., CPA, Director (Age 60) Mr. Freitag has been a member of our Board of Directors since September 2011. ... Mr. Freitag was Axogen’s Special Counsel from June 2020 until his retirement in March 2021, General Counsel from September 2011 until June 2020, Chief Financial Officer from September 2011 to May 2014 and August 2015 to March 2016 and Senior Vice President Business Development from May 2014 until October 2018. ... Messrs. Johnson (Chairman), and Levine and Ms. Wendell and Dr. Gold are members of the Audit Committee. Messrs. Neels (Chairman), Levine and Thomas are members of the Compensation Committee. Ms. Wendell (Chairman) and Messrs. Neels, Johnson and Thomas are members of the Governance, Nominating and Sustainability Committee. Messrs. Johnson (Chairman) and Freitag and Dr. Gold are members of the Quality, Compliance and Portfolio Management Committee.
2023-07-07	None